| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $59.5M | +14.4% |
| SG&A Expense | $30.3M | +13.2% |
| Operating Income | -$609.6M | -745.7% |
| Interest Expense | $16.5M | +274.0% |
| Pre-tax Income | -$614.9M | -680.5% |
| Net Income | -$614.9M | -680.5% |
| EPS (Basic) | -$0.99 | -141.5% |
| EPS (Diluted) | -$0.99 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.4M | -79.5% |
| Short-term Investments | $114.8M | — |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $189.7M | -71.1% |
| Total Assets | $202.9M | -69.4% |
| Current Liabilities | $20.4M | -47.4% |
| Total Liabilities | $125.3M | -76.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$76.8M | -84.6% |
| Capital Expenditures | $128K | -79.5% |
| Investing Cash Flow | -$587.8M | — |
| Financing Cash Flow | $86.5M | -86.1% |
| Free Cash Flow | -$76.9M | -82.2% |
| -141.5% |
| Stockholders' Equity |
| $77.7M |
| -38.7% |